1,25D acts directly on enthesis cells to suppress BMP and IHH signaling and can prevent enthesopathy in Hyp and C–/– mice if 1,25D therapy is initiated early in postnatal development, indicating that 1,25D signaling is protective against enthesopathy development. Here, IHH is linked to enthesopathy.